期刊文献+

噻托溴胺粉吸入剂对稳定期慢性阻塞性肺疾病的疗效观察 被引量:9

The Clinical Effect of Inhaling Tiotropium in Stable Chronic Obstructive Pulmonary Disease
下载PDF
导出
摘要 目的:观察噻托溴胺粉吸入剂在治疗稳定期慢性阻塞性肺疾病患者的临床疗效。方法:选择50例确诊为慢性阻塞性肺疾病稳定期的患者,随机分为两组,治疗组(n=25)吸入噻托溴胺粉剂18 ug/次,1次/d;对照组(n=25)按需使用异丙托溴胺气雾剂,观察两组用药前、后3、6个月肺功能的变化,通过6 min步行试验(6MWT)观察运动耐力的变化,评价药物疗效。结果:用药3个月后治疗组FEVl、FVC、FEVl/FVC、FEVl占预计值百分比比对照组明显改善,两组比较差异有统计学意义(P<0.05),治疗组运动耐力增加,与对照组比较差异有统计学意义(P<0.05);治疗组用药后3、6个月肺功能比较无统计学意义(P>0.05)。结论:吸入噻托溴胺可以改善稳定期慢性阻塞性肺疾病患者肺功能与运动耐力,安全可靠,依从性好。 Objective:To observe the clinical effect of therapy with inhaling of tiotropium in stable chroni cobstructive pulmonary disease.Methods: Fifty patients with stable COPD were randomly divided into tow groups,treatment group and control group.25 patients in treatment group received tiotropium inhalation 18 ug once perday;The other 25 patients in control group inhale ipratropium necessaryly.Tests for lung function in patients of these two groups were examined and compared with each other before and 3、6 month after the therapeutic course.According to 6 mintue walk test(6MWT),chanles of sport patience were compared of two groups after three months.Results: The values of FEVl、FVC、FEVl/FVC%、 and FEVl /predictive% in the treatment group were significantly increased in different extent than the control group(P0.05)after treatment.In treatment group,the 6 MWT was improved significantly(P0.05);lung function were not different after treatment 3 month and 6 month(P0.05).Conclusion:Tiotropium inhalation can effectively improve lung function,exercise endurance in patients with stable COPD.
出处 《内蒙古医学杂志》 2011年第1期26-28,共3页 Inner Mongolia Medical Journal
关键词 慢性阻塞性肺疾病 噻托溴胺 肺功能 稳定期 Chronic obstructive pulmonary disease(COPD) Tiotropium Lung function Stable stage.
  • 相关文献

参考文献6

二级参考文献22

  • 1有创-无创序贯机械通气多中心研究协作组.以肺部感染控制窗为切换点行有创与无创序贯机械通气治疗慢性阻塞性肺疾病所致严重呼吸衰竭的随机对照研究[J].中华结核和呼吸杂志,2006,29(1):14-18. 被引量:279
  • 2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8235
  • 3Littner MR,Ilowite JS,Tashkin DP,et al.Long-acting bronchodilation with once-daily dosing of tiotropium in stable chronic obstructive pulmonary disease.Am J Respir Crit Care Med,2000,161(4):1136-1142.
  • 4Koumis T,Samuel S.Tiotropium bromide:a new long-acting bronchodilator for the treatment of chronic obstructive pulmonary disease.Clin Ther,2005,27(4):377-392.
  • 5Panning CA,DeBisschop M.Tiotropium:an inhaled,long-acting anticholinergic drug for chronic obstructive pulmonary disease.Pharmacotherapy,2003,23(2):183-189.
  • 6Vincken W,vanNoord JA,Greefhorst AP,et al.Improved health outcomes in patients with COPD during one year treatment with tiotropium.Eur Respir J,2002,19(2):209-216.
  • 7Dusser D,Bravo ML,Iacono P.The effect of tiotropium on exacerbations and airflow in patients with COPD[J].Eur Respir J,2006,27(3):547-555.
  • 8GOLD Executive Committee[DB/OL].Guidelines:Global Strategy for Diagnosis,Management,and Prevention of COPD,November 2006[2006-11-18].http://www.goldcopd.com/Guidelineitem.asp? l1 =2-12 = 1&intId =989.
  • 9Celli BR,MacNee W,Committee members.Standard for the diagnosis and treatment of patients with COPD:a summary of the ATS/ERS position paper.Eur Respir J,2004,23:932-946.
  • 10Celli BR,Cote CG,Marin JM,ct al.The body mass index,airflow obstruction,dyspnea and exercise capacity index in chronic obstructive pulmonary disease.N Engl J Med,2004,350:1005-1012.

共引文献8244

同被引文献38

引证文献9

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部